Galleri Test : Identifies The Original Site Of Cancer
A blood test capable of detecting over 50 types of cancer has shown remarkable potential in a major trial conducted by the NHS.
- Galleri test, has demonstrated high accuracy rates and the ability to identify the original site of cancer in a significant percentage of positive cases.
- It aims to revolutionize cancer detection by identifying treatable cancer at an early stage, thus offering a chance to save lives.
- In the trial, two-thirds (66.6%) of the cancers among the 5,000 participants with suspected symptoms were accurately identified through this blood test.
- Remarkably, in 85% of these positive cases, the Galleri test successfully pinpointed the original site of the cancer.
- Traditional methods, such as scans and biopsies, subsequently diagnosed over 350 participants with cancer in the study.
- Among those who tested positive on the blood test, an impressive 75% were confirmed to have cancer through traditional methods.
- Even among those who initially tested negative, 2.5% were later diagnosed with cancer.
- Although not infallible, the Galleri test exhibited an 85% accuracy rate in detecting the source of cancer.
